By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to41.1M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States41.1M100.00%